A Study to Evaluate Safety and Efficacy of TP-05 in Healthy Participants With Tick Exposure (NCT07562087)

🧪 Interventions in This Study

• TP-05 (lotilaner) Low Dose (DRUG)
• TP-05 (lotilaner) High Dose (DRUG)
• Placebo (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (19 Sites)

• Study Site — Pikesville, Maryland
• Study Site — Brookline, Massachusetts
• Study Site — Fall River, Massachusetts
• Study Site — Minneapolis, Minnesota
• Study Site — Marlboro, New Jersey
• Study Site — Albany, New York
• Study Site — Binghamton, New York
• Study Site — Buffalo, New York
• Study Site — East Syracuse, New York
• Study Site — Middletown, New York
• Study Site — New York, New York
• Study Site — Rochester, New York
• Study Site — Erie, Pennsylvania
• Study Site — Hatboro, Pennsylvania
• Study Site — Philadelphia, Pennsylvania
• Study Site — Pittsburgh, Pennsylvania
• Study Site — Pottstown, Pennsylvania
• Study Site — West Chester, Pennsylvania
• Study Site — Warwick, Rhode Island

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Lyme Disease

• A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1982 to Prevent Lyme Disease in Healthy Participants (18 to 70 Years of Age) — Truro, Nova Scotia
• A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of 6-Valent OspA-Based Lyme Disease Vaccine — Bangor, Maine
• Evaluation, Treatment, and Follow-up of Patients With Lyme Disease — Bethesda, Maryland
• Pregnancy and Early Neurodevelopmental Outcomes Following In Utero Lyme Disease Exposure — Washington D.C., District of Columbia
• A Comprehensive Clinical, Microbiological and Immunological Assessment of Patients With Suspected Post Treatment Lyme Disease Syndrome and Selected Control Populations — Bethesda, Maryland

Explore by condition: All Lyme Disease clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.